Join us for Inside Precision Medicine’s FREE State of Precision Medicine Summit on Wednesday, March 5th, 2025.
One of the key highlights is the “State of Molecular Diagnostics” panel at 2:30pm EST, featuring industry leaders including Virax Biolab’s COO, Dr Nigel McCracken, and moderated by North American Editor Jonathan D. Grinstein, PhD.
“Preparing for Potential Vaccine Regulatory Changes”: Virax CEO, James Foster, discusses how the industry is preparing for potential regulatory changes to vaccine policy
Article by Mike Hollan
Virax Biolabs Believes Technology Aligns with Unites States Department of Health and Human Services’ Transparency Priority on Vaccine Efficacy
“What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances”: Industry leaders including Virax CEO, James Foster, share their expectations for the year ahead
Article by Eleanor Malone
“Global Launch Strategies in the Current Political Climate”: Virax CEO, James Foster, discusses how global launches are being impacted by changing geopolitical conditions
Article by Mike Hollan
“Lyme Disease: Are we Close to an Effective Diagnostic Test?”: Dr. Nigel McCracken speaks to Clinical Lab Products Magazine
Article by Chris Wolski
“Combating chronic inflammation through immune diagnostics”: Dr. Nigel McCracken speaks to Longevity.Technology
Article by Eleanor Garth
Virax Biolabs’ CEO James Foster Issues Letter to Shareholders
Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland
Virax Biolabs: Interview With COO Nigel McCracken About The Diagnostics And Detection Company
by Amit Chowdhry of Pulse 2.0